News | Patient Positioning Radiation Therapy | July 03, 2019

Couchtop allows effective proton therapy treatment of central nervous system cancers

Civco Displaying Universal Couchtop ProForm Head & Neck Solution at AAPM

July 3, 2019 — The upcoming release of Civco’s Universal Couchtop ProForm Head & Neck Solution will allow proton therapy centers direct access to effectively treat central nervous system (CNS) cancer patients.

The extension is quick and easy to attach and features a large, 121.5 cm junction-free and artifact-free treatment area. The ProForm contains a homogeneous treatment area with soft gradient edges that reduce beam degradation. ProForm accepts a thermoplastic mask with a smaller profile frame and pin similar to Civco’s Type-S system. The ProForm solution follows the Universal Couchtop release with IBA’s Proteus One and Proteus Plus. Utilizing the Universal Couchtop allows dosimetric consistency with computed tomography (CT) simulation, photon and proton treatment compatible models, improving clinic workflow.

Civco will display the Universal Couchtop at the 2019 American Association of Physicists in Medicine (AAPM) annual meeting, July 14-18 in San Antonio, Texas.

For more information: www.civcort.com

Related Content

Feature | Radiology Business | By Melinda Taschetta-Millane

Did you know that Imaging Technology News (ITN) maintains more than 40 comparison charts of product specifications from ...

Time August 12, 2022
arrow
News | ASTRO

August 12, 2022 — The American Society for Radiation Oncology (ASTRO) today expressed its support for President Joseph R ...

Time August 12, 2022
arrow
News | Lung Imaging

August 10, 2022 — Mount Sinai is leading a team of lung cancer researchers that has been awarded a three-year, $500,000 ...

Time August 10, 2022
arrow
News | Prostate Cancer

August 9, 2022 — Bot Image, an Omaha-based MRI medical device company has developed an AI-driven medical device CAD ...

Time August 09, 2022
arrow
News | Breast Imaging

August 8, 2022 — The U.S. Food and Drug Administration approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV ...

Time August 08, 2022
arrow
News | Lung Imaging

August 8, 2022 — Representatives from the Diagnostics Working Group of the IASLC Early Detection and Screening Committee ...

Time August 08, 2022
arrow
News | Lung Imaging

August 8, 2022 — A clinical trial is only as powerful as its participants. For years, researchers have struggled to fill ...

Time August 08, 2022
arrow
News | Proton Therapy

August 5, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, Fred ...

Time August 05, 2022
arrow
News | Radiology Business

August 4, 2022 — The Biden Administration, through the U.S. Department of Health and Human Services and the Centers for ...

Time August 04, 2022
arrow
News | Pediatric Imaging

August 3, 2022 — The Jack Martin Fund (JMF) has built on its partnership with the Mount Sinai Health System to provide ...

Time August 03, 2022
arrow
Subscribe Now